Amneal Pharmaceuticals (AMRX) Receivables (2017 - 2026)
Amneal Pharmaceuticals (AMRX) posted quarterly Receivables of $6.6 million for Q1 2026, down 99.5% year-over-year from $1.3 billion in Q1 2025, and up 15.24% quarter-over-quarter from $5.7 million in Q4 2025.
Amneal Pharmaceuticals (AMRX) Receivables (2017 - 2026) Analysis & Trends
Amneal Pharmaceuticals' Receivables history runs 10 years deep, the most recent figure standing at $6.6 million for Q1 2026.
- In Q1 2026, Receivables fell 99.5% year-over-year to $6.6 million; the TTM figure through Mar 2026 stood at $6.6 million (down 99.5% YoY), while the FY2025 annual figure was $5.7 million, up 16.18% from the prior year.
- Receivables for Q1 2026 stood at $6.6 million, up from $5.7 million in the prior quarter.
- The five-year high for Receivables was $1.5 billion in Q3 2025, with the low at $486000.0 in Q4 2022.
- The 5-year median for Receivables is $1.1 billion (2022), against an average of $811.4 million.
- The sharpest annual moves came in 2022 and 2024: Receivables sank 99.93% in 2022, then surged 111.05% in 2024.
- Amneal Pharmaceuticals' Receivables stood at $486000.0 in 2022, then soared by 248585.6% to $1.2 billion in 2023, then slumped by 99.59% to $4.9 million in 2024, then grew by 16.18% to $5.7 million in 2025, then increased by 15.24% to $6.6 million in 2026.
- Business Quant data shows AMRX's Receivables at $6.6 million in Q1 2026, $5.7 million in Q4 2025, and $1.5 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.23 Bn | 43.26 Bn | - | 3.07 Bn |
| 2 | Teva Pharmaceutical Industries | 43.48 Bn | 39.82 Bn | 2.15 Bn | 3.49 Bn |
| 3 | Zoetis | 31.99 Bn | 30.32 Bn | 1.05 Bn | 1.57 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.81 Bn | 5.10 Bn | 5.84 Bn |
| 5 | United Therapeutics | 22.30 Bn | 19.64 Bn | 683.80 Mn | 310.30 Mn |
| 6 | Viatris | 18.76 Bn | 17.88 Bn | 1.46 Bn | 3.67 Bn |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn | 887.00 Mn |
| 8 | Elanco Animal Health | 12.00 Bn | 11.47 Bn | 798.00 Mn | 1.15 Bn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.92 Bn | - | 1.08 Bn |
| 10 | Amneal Pharmaceuticals | 5.71 Bn | 5.58 Bn | 334.51 Mn | 1.61 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.61 Bn |
| Mar 31, 2026 | 6.58 Mn |
| Dec 31, 2025 | 5.71 Mn |
| Sep 30, 2025 | 1.46 Bn |
| Jun 30, 2025 | 1.35 Bn |
| Mar 31, 2025 | 1.30 Bn |
| Dec 31, 2024 | 4.91 Mn |
| Sep 30, 2024 | 1.22 Bn |
| Jun 30, 2024 | 1.25 Bn |
| Mar 31, 2024 | 1.16 Bn |
| Sep 30, 2023 | 1.21 Bn |
| Jun 30, 2023 | 1.15 Bn |
| Mar 31, 2023 | 549.07 Mn |
| Dec 31, 2022 | 486,000.00 |
| Sep 30, 2022 | 1.04 Bn |
| Jun 30, 2022 | 690.54 Mn |
| Mar 31, 2022 | 585.52 Mn |
| Dec 31, 2021 | 667.58 Mn |
| Sep 30, 2021 | 630.07 Mn |
| Jun 30, 2021 | 653.32 Mn |